Cargando…
Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity and Prognostic Factors on 142 Patients (STEP Study)
Aim: The gold standard of care for pancreatic adenocarcinoma is the integrated treatment of surgery and chemotherapy (ChT), but about 50% of patients present with unresectable disease. Our study evaluated the efficacy in terms of local control, survival and safety of stereotactic body radiation ther...
Autores principales: | Comito, Tiziana, Massaro, Maria, Teriaca, Maria Ausilia, Franzese, Ciro, Franceschini, Davide, Navarria, Pierina, Clerici, Elena, Di Cristina, Luciana, Bertolini, Anna, Tomatis, Stefano, Reggiori, Giacomo, Bresolin, Andrea, Bozzarelli, Silvia, Rimassa, Lorenza, Bonifacio, Cristiana, Carrara, Silvia, Santoro, Armando, Zerbi, Alessandro, Scorsetti, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378012/ https://www.ncbi.nlm.nih.gov/pubmed/37504373 http://dx.doi.org/10.3390/curroncol30070513 |
Ejemplares similares
-
SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience
por: Tozzi, Angelo, et al.
Publicado: (2013) -
Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up
por: Scorsetti, Marta, et al.
Publicado: (2018) -
Adaptive Volumetric-Modulated Arc Radiation Therapy for Head and Neck Cancer: Evaluation of Benefit on Target Coverage and Sparing of Organs at Risk
por: Franzese, Ciro, et al.
Publicado: (2023) -
The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation
por: Cozzi, Luca, et al.
Publicado: (2020) -
Knowing When to Use Stereotactic Ablative Radiation Therapy in Oligometastatic Cancer
por: Franceschini, Davide, et al.
Publicado: (2021)